Abbott India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2025 ,inter alia, to consider and approve unaudited financial results for ....
ABBOTINDIA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Abbott India has informed BSE that its Board of Directors will meet on November 6, 2025 to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2025. The company has also confirmed that its trading window remains closed from October 1, 2025 to November 8, 2025, covering the period until results are announced. This is a standard regulatory intimation under SEBI Listing Regulations. No financial figures or business details have been disclosed in this filing.
This is a routine pre-results announcement and does not signal any change in business outlook. Investors should wait for the actual Q2/H1 FY26 results on November 6 to assess the company's performance and any potential impact on the stock price.